Clinical trial
Real-World Clinical Outcomes of GENOSS PCB (Paclitaxel-coated Balloon) for Femoropopliteal Artery Disease: A Prospective, Multicenter, Observational Study
NCT07399080 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Clinical Outcomes of GENOSS PCB (Paclitaxel-coated Balloon) for Femoropopliteal Artery Disease: A Prospective, Multicenter, Observational Study
- Lead sponsor
- Genoss Co., Ltd.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2025
- Completion date
- June 30, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
femoropopliteal artery disease, pta (percutaneous transluminal angioplasty )